Costs of colorectal cancer screening provision in CDC's Colorectal Cancer Control Program: Comparisons of colonoscopy and FOBT/FIT based screening

Evaluation and Program Planning

Volumn 62, Issue , 2017, Pages 73-80

  Subramanian, Sujha ^a   Tangka, Florence K L ^b   Hoover, Sonja ^a   Royalty, Janet ^b   DeGroff, Amy ^b   Joseph, Djenaba ^b  

^a RTI INTERNATIONAL   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Activity based costing; Colorectal cancer screening; Economic evaluation; Screening cost

Indexed keywords

CANCER; COMPARATIVE STUDY; COST ANALYSIS; HEALTH SERVICES;

COLONOSCOPY; COLORECTAL TUMOR; COST BENEFIT ANALYSIS; EARLY CANCER DIAGNOSIS; ECONOMICS; HUMAN; OCCULT BLOOD; PROCEDURES; PROGRAM EVALUATION; PUBLIC HEALTH SERVICE; UNITED STATES;

CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); COLONOSCOPY; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; HUMANS; OCCULT BLOOD; PROGRAM EVALUATION; UNITED STATES;

EID: 85011966507     PISSN: 01497189     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.evalprogplan.2017.02.007     Document Type: Article

References (25)

1. Centers for Disease Control and Prevention, Vital signs: Colorectal cancer screening test use—United States, 2012. MMWR. Morbidity and Mortality Weekly Report 62 (2013), 881–888.
2. Drummond, M., Schulpher, M., Torrance, G., O'Brien, B., Stoddard, G., Methods for the economic evaluation of health care programmes. 2005, Oxford University Press, Oxford, England.
3. Ekwueme, D.U., Subramanian, S., Trogdon, J.G., Miller, J.W., Royalty, J.E., Li, C., et al. Cost of services provided by the national breast and cervical cancer early detection program. Cancer 120:Suppl. 16 (2014), 2604–2611.
4. Fisher, J.A., Fikry, C., Troxel, A.B., Cutting cost and increasing access to colorectal cancer screening: Another approach to following the guidelines. Cancer Epidemiology, Biomarkers and Prevention 15 (2006), 108–113.
5. National Colorectal Cancer Roundtable (n.d.). Tools & resources—80% [screening rate] by 2018. National Colorectal Cancer Roundtable. Accessed from http://nccrt.org/tools/80-percent-by-2018.
6. National Governors Association Center for Best Practices (2008). State strategies for curbing colorectal cancer. Washington, DC: National Governors Association Center for Best Practices. Accessed October 22, 2008 from http://www.nga.org/files/live/sites/NGA/files/pdf/0806CURBCANCER.PDF.
7. Pignone, M., Russell, L., Wagner, J., 2005. Economic models of colorectal cancer screening in average-risk adults: workshop summary, Publishing, Washington, DC.
8. Rex, D.K., Johnson, D.A., Anderson, J.C., Schoenfeld, P.S., Burke, C.A., Inadomi, J.M., et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. American Journal of Gastroenterology 104 (2009), 739–750.
9. Sabatino, S.A., White, M.C., Thompson, T.D., Klabunde, C.N., Cancer screening test use—United States, 2013. MMWR. Morbidity and Mortality Weekly Report 64 (2015), 464–468.
10. Salome, H.J., French, M.T., Miller, M., McLellan, A.T., Estimating the client costs of addiction treatment: First findings from the client drug abuse treatment cost analysis program (Client DATCAP). Drug and Alcohol Dependence 71 (2003), 195–206.
11. Seeff, L.C., Rohan, E.A., Lessons learned from the CDC's colorectal cancer screening demonstration program. Cancer 119:Suppl. 15 (2013), 2817–2819.
12. Smith, R.A., Manassaram-Baptiste, D., Brooks, D., Doroshenk, M., Fedewa, S., Saslow, D., et al. Cancer screening in the United States, 2015: A review of current American cancer society guidelines and current issues in cancer screening. CA: A Cancer Journal for Clinicians 65 (2015), 30–54.
13. Subramanian, S., Ekwueme, D.U., Gardner, J.G., Bapat, B., Kramer, C., Identifying and controlling for program-level differences in comparative cost analysis: Lessons from the economic evaluation of the National Breast and Cervical Cancer Early Detection Program. Evaluation and Program Planning 31 (2008), 136–144.
14. Subramanian, S., Ekwueme, D.U., Gardner, J.G., Trogdon, J., Developing and testing a cost-assessment tool for cancer screening programs. American Journal of Preventive Medicine 37 (2009), 242–247.
15. Subramanian, S., Bobashev, G., Morris, R.J., When budgets are tight: There are better options than colonoscopies for colorectal cancer screening. Health Affairs 29 (2010), 1734–1740.
16. Subramanian, S., Tangka, F.K., Hoover, S., Beebe, M.C., DeGroff, A., Royalty, J., et al. Costs of planning and implementing the CDC's colorectal cancer screening demonstration program. Cancer 119:Suppl. 15 (2013), 2855–2862.
17. Tangka, F., Subramanian, S. (under review). Importance of implementation economics for program planning −the case for colorectal cancer control program.
18. Tangka, F.K., Subramanian, S., Beebe, M.C., Hoover, S., Royalty, J., Seeff, L.C., Clinical costs of colorectal cancer screening in 5 federally funded demonstration programs. Cancer, 119(Suppl. 15), 2013, 286.
19. Tangka, F.K.L., Subramanian, S., Hoover, S., Royalty, J., Joseph, K., DeGroff, A., Costs of promoting cancer screening: Evidence from CDC's colorectal cancer control program (CRCCP). Preventing Chronic Disease, 2016.
20. Trogdon, J.G., Ekwueme, D.U., Subramanian, S., Crouse, W., Economies of scale in federally-funded state-organized public health programs: Results from the National Breast and Cervical Cancer Early Detection Programs. Health Care Management Science 17 (2014), 321–330.
21. U.S. Cancer Statistics Working Group (2015). United States cancer statistics: 1999–2012 incidence and mortality. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Contro and Prevention and National Cancer Institute. Accessed March 6, 2016
22. Vijan, S., Hwang, I., Inadomi, J., Wong, R.K., Choi, J.R., Napierkowski, J., et al. The cost-effectiveness of CT colonography in screening for colorectal neoplasia. American Journal of Gastroenterology 102 (2007), 380–390.
23. Whitlock, E.P., Lin, J.S., Liles, E., Beil, T.L., Fu, R., Screening for colorectal cancer: A targeted, updated systematic review for the U.S. Preventive Services Task Force. Annals of Internal Medicine 149 (2008), 638–658.
24. Winawer, S., Fletcher, R., Rex, D., Bond, J., Burt, R., Ferrucci, J., et al. Colorectal cancer screening and surveillance: Clinical guidelines and rationale-update based on new evidence. Gastroenterology 124 (2003), 544–560.
25. Zauber, A.G., Lansdorp-Vogelaar, I., Wilschut, J., Knudsen, A.B., van Ballegooijen, M., & Kuntz, K.M. (2007). Cost-effectiveness of DNA stool testing to screen for colorectal cancer: report to AHRQ and CMS from the Cancer Intervention and Surveillance Modeling Network (CISNET) for MISCAN and SimCRC models. Rockville, MD: Agency for Healthcare Research and Quality. Accessed June 1, 2015 from https://www.cms.hhs.gov/mcd/viewtechassess.asp?from2=viewtechassess.asp&id=212.